# Aloe barbadensis

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/aloe-barbadensis
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-29
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Aloe vera, Barbados aloe, Aloe barbadensis Mill., Cape aloe, Curacao aloe, Socotrine aloe, Aloe latex, Aloe succus siccatus, Dried aloe juice

## Overview

Aloe barbadensis is a succulent plant whose latex fraction contains anthraquinone glycosides, primarily barbaloin (aloin A and B), which act as stimulant laxatives in the large intestine. These compounds are hydrolyzed by colonic bacteria into active aloe-emodin anthrones, increasing intestinal motility and fluid secretion to relieve constipation.

## Health Benefits

• Short-term relief of occasional constipation - Traditional use recognized by EMA/HMPC based on pre-2006 marketing authorizations, though lacking recent clinical trials
• Stimulant laxative effect - Well-established use under Article 10a of Directive 2001/83/EC for bowel regulation
• Folk medicine applications for dermatitis and ulcers - No experimental or clinical support documented
• Traditional claims for blood sugar reduction - Unverified in clinical studies
• Historical use for fungal infections - No modern evidence supporting efficacy

## Mechanism of Action

Barbaloin (aloin A and B) passes unabsorbed through the small intestine and is metabolized by colonic microbiota into aloe-emodin anthrones, the pharmacologically active metabolites. These anthrones inhibit Na+/K+-ATPase in colonocyte membranes, reducing sodium and water absorption while stimulating chloride secretion, increasing luminal fluid content. Simultaneously, aloe-emodin anthrones stimulate [prostaglandin](/ingredients/condition/inflammation) E2 synthesis and activate enteric neurons, accelerating peristaltic contractions in the large intestine.

## Clinical Summary

The European Medicines Agency (EMA) Committee on Herbal Medicinal Products (HMPC) granted Aloe barbadensis latex 'well-established use' status under Article 10a of Directive 2001/83/EC for short-term treatment of occasional constipation, based on documentation predating 2006 rather than recent randomized controlled trials. A limited number of older clinical studies with small sample sizes (typically under 100 participants) demonstrated onset of laxative effect within 6–12 hours of oral administration of standardized aloin doses of 20–30 mg. Quantified outcomes in these studies showed increased stool frequency and softer stool consistency, but high-quality double-blind RCTs with pre-registered protocols are absent from the modern literature. The evidence base is therefore classified as 'traditional use' in contemporary regulatory frameworks, meaning efficacy is plausible but not robustly confirmed by current clinical trial standards.

## Nutritional Profile

Aloe barbadensis (Aloe vera) latex and gel contain distinct nutritional and bioactive profiles. Aloe latex (from pericyclic cells beneath the rind) is rich in anthraquinone glycosides, primarily aloin A and aloin B (barbaloin) at concentrations of 15–40% of dry weight, which are the primary laxative constituents. Aloe gel (inner leaf parenchyma) contains approximately 98.5–99.5% water; dry matter includes polysaccharides (acemannan, glucomannans) at 0.2–0.5% fresh weight, which contribute to viscosity and potential [immunomodulatory](/ingredients/condition/immune-support) effects. Protein content is low at approximately 0.1% fresh weight, comprising lectins and glycoproteins (e.g., aloctin A, B). Minerals present include calcium (~9.4 mg/100g), magnesium (~8.8 mg/100g), potassium (~150 mg/100g), sodium, zinc, and manganese at trace levels. Vitamins detected include vitamin C (~4.4 mg/100g fresh gel), vitamin E (alpha-tocopherol, ~0.04 mg/100g), B1, B2, B6, and choline at low concentrations. Bioactive compounds include anthraquinones (aloe-emodin, emodin, chrysophanol), chromones (aloesin, aloeresins), sterols (beta-sitosterol, campesterol, lupeol), and saponins. Bioavailability note: anthraquinone glycosides are poorly absorbed in the small intestine, reaching the colon where gut bacteria hydrolyze them to active aglycones (aloe-emodin) responsible for stimulant laxative action; acemannan has limited oral bioavailability and is partially degraded by intestinal microbiota before absorption.

## Dosage & Preparation

For standardized dry extracts (folii succus siccatus): 5-15 mg hydroxyanthracene derivatives (HADs) daily, equivalent to 10-30 mg barbaloin, for short-term use not exceeding 1-2 weeks. Standardization requires not less than 28% HADs expressed as barbaloin per European Pharmacopoeia. No dosages specified for non-latex forms like gel or powder. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Aloe barbadensis latex is contraindicated in individuals with intestinal obstruction, [inflammatory](/ingredients/condition/inflammation) bowel conditions (Crohn's disease, ulcerative colitis), appendicitis, abdominal pain of unknown origin, and severe dehydration with electrolyte imbalances. Chronic use or overuse can cause hypokalemia (low potassium), which may potentiate the effects of cardiac glycosides such as digoxin and interact with antiarrhythmic drugs; concurrent use with thiazide diuretics or corticosteroids further increases electrolyte depletion risk. Use is contraindicated during pregnancy due to potential stimulation of uterine contractions and is not recommended during breastfeeding, as anthraquinone metabolites may pass into breast milk. The EMA restricts recommended use to a maximum of 1–2 weeks without medical supervision, and long-term use is associated with melanosis coli (a benign but reversible pigmentation of the colon).

## Scientific Research

EMA/HMPC monographs note a lack of recent clinical trials supporting well-established use beyond traditional evidence. No key human RCTs, meta-analyses, or specific PubMed PMIDs for efficacy are detailed in the sources for short-term relief of occasional constipation. Pre-2006 data underpin well-established use based on marketing authorizations, but no specific study designs, sample sizes, or outcomes from modern trials are provided.

## Historical & Cultural Context

Used historically as a purgative/laxative in European traditional medicine for occasional constipation, with well-established use recognized by EMA/HMPC based on long market presence. Documented in pharmacopeias since at least 1962, with folk uses in WHO monographs including unverified claims for dermatitis, ulcers, tuberculosis, and fungal infections.

## Synergistic Combinations

Psyllium husk, Senna, Cascara sagrada, Magnesium citrate, [Probiotic](/ingredients/condition/gut-health)s

## Frequently Asked Questions

### What is the difference between aloe vera gel and aloe barbadensis latex?

Aloe barbadensis latex is the bitter yellow fluid derived from the inner leaf skin (just beneath the outer rind), rich in anthraquinone glycosides like aloin A and B with potent laxative activity. Aloe vera gel, by contrast, is the clear mucilaginous pulp from the inner leaf parenchyma, containing polysaccharides such as acemannan but virtually no anthraquinones, and is used primarily for topical wound healing and gastrointestinal soothing rather than stimulant laxation.

### How long does aloe barbadensis take to work as a laxative?

The laxative effect of Aloe barbadensis latex typically occurs within 6 to 12 hours after oral ingestion, reflecting the time required for barbaloin to transit to the colon and be converted by gut bacteria into active aloe-emodin anthrones. This delayed onset is characteristic of all anthraquinone-based stimulant laxatives, which is why doses are commonly taken in the evening to produce a bowel movement the following morning.

### What is the recommended dose of aloe barbadensis for constipation?

The EMA-recognized dose for standardized Aloe barbadensis latex preparations is 20–30 mg of hydroxyanthracene derivatives (calculated as anhydrous aloin) per day for adults and children over 12 years of age. This should be taken as the lowest effective dose for the shortest necessary duration, not exceeding 1–2 weeks of continuous use without consulting a healthcare provider.

### Is aloe barbadensis safe to take every day?

Daily long-term use of Aloe barbadensis latex is not considered safe and is specifically discouraged by the EMA, which limits recommended use to 1–2 weeks. Prolonged use can cause electrolyte imbalances, particularly hypokalemia, and is associated with melanosis coli, a reversible darkening of the colon lining caused by anthraquinone pigment deposition; dependency and reduced bowel muscle tone (atonic colon) have also been reported with chronic stimulant laxative use.

### Does aloe barbadensis interact with any medications?

Yes, Aloe barbadensis latex has clinically significant interactions with several drug classes. Its potassium-depleting effect can amplify the toxicity of cardiac glycosides such as digoxin, since hypokalemia increases myocardial sensitivity to these drugs. Combined use with thiazide diuretics, loop diuretics, or corticosteroids compounds electrolyte loss, and concomitant use with antiarrhythmic agents that are affected by potassium levels (e.g., quinidine, sotalol) should be avoided.

### Is aloe barbadensis safe during pregnancy and breastfeeding?

Aloe barbadensis is not recommended during pregnancy, as stimulant laxatives may increase the risk of uterine contractions and potentially affect pregnancy outcomes. It is also not advised during breastfeeding, as anthraquinone compounds may pass into breast milk and affect infants. Pregnant and nursing women should consult a healthcare provider before use.

### Is aloe barbadensis safe for children?

Aloe barbadensis is generally not recommended for children under 12 years of age without medical supervision, as pediatric dosing has not been well-established. The stimulant laxative effects may be too strong for a child's digestive system and could cause electrolyte imbalances with prolonged use. Parents should consult a pediatrician before giving aloe barbadensis to children.

### What is the difference between traditional use and modern clinical evidence for aloe barbadensis?

Aloe barbadensis has long traditional use recognized by the EMA/HMPC for short-term constipation relief based on pre-2006 marketing authorizations, but lacks recent robust clinical trial data to support its efficacy. While its stimulant laxative mechanism is well-established and documented, folk medicine claims for dermatitis and ulcer treatment remain unsupported by experimental or clinical evidence. Modern regulatory approval is primarily based on historical use rather than contemporary scientific studies.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*